Entre as marcas dos nossos mais de 25 parceiros, destaca-se a TargetMol
We have reached an agreement with TargetMol: CymitQuimica clients will benefit for a 20% discount on all TargetMol products until the end of the year.On our website you can find the products offered by this partner, which has become one of the world's most recognised compound libraries and small molecule inhibitors supplier. TargetMol offers approximately 120 compound libraries and a wide range of chemical products and kits for life sciences.
Termina em 31 de dez.( faltam 8 dias )
HPK1-IN-33
CAS:HPK1-IN-33 inhibits HPK1 with 1.7 nM potency, reduces IL-2 in Jurkat cells with 286 nM EC50, and is less effective in HPK1 KO cells.Fórmula:C18H16ClFN6Cor e Forma:SolidPeso molecular:370.81BAY1125976
CAS:<p>BAY1125976 is an allosteric inhibitor of Akt1 and Akt2 (IC50s of 5.2 and 18 nM, respectively, in a time-resolved FRET assay)</p>Fórmula:C23H21N5OPureza:99.28% - ≥98%Cor e Forma:SolidPeso molecular:383.45PI3K-IN-36
CAS:PI3K-IN-36 is a potent inhibitor of PI3K, suitable for research applications in follicular lymphoma (FL).Fórmula:C30H36F2N8OCor e Forma:SolidPeso molecular:562.66USP22-IN-1
CAS:<p>USP22-IN-1 is a ubiquitin-specific peptidase 22 (USP22) inhibitor that can be used to treat proliferative diseases or cancer.</p>Fórmula:C22H18N4Pureza:98.2%Cor e Forma:SolidPeso molecular:338.41SLU-PP-915
CAS:SLU-PP-915, ERR agonist, EC50 ~400 nM for ERRα/β/γ, may aid oxidative metabolism & heart health.Fórmula:C17H13BFNO3SCor e Forma:SolidPeso molecular:341.16EGFR-IN-69
CAS:EGFR-IN-69: Potent EGFR inhibitor for NSCLC research; IC50: 4.3-25.6 nM against various EGFR mutations.Fórmula:C31H37Cl2N7O3SCor e Forma:SolidPeso molecular:658.64EGFR-IN-70
EGFR-IN-70: potent EGFR inhibitor, IC50 of 23.6 nM (LR/TM/CS), 307.5 nM (WT), anti-proliferative, inhibits EGFR phosphorylation, for cancer research.Fórmula:C31H36ClN5O5SCor e Forma:SolidPeso molecular:626.17BMS-986339
CAS:BMS-986339: oral, potent FXR agonist; binds to His298/ASN287; for PBC, PSC, NASH, anti-fibrosis research.Fórmula:C35H41F4N3O4Cor e Forma:SolidPeso molecular:643.71LabMol-301
CAS:LabMol-301 blocks NS5 RdRp/NS2B-NS3pro (IC50: 0.8/7.4µM), protects cells from ZIKV death.Fórmula:C18H16N6Cor e Forma:SolidPeso molecular:316.36LY2828360
CAS:LY2828360: CB2 agonist, Ki=40.3 nM; biases CB2 over CB1 with EC50s of 20.1 nM and >100 μM.Fórmula:C22H27ClN6OPureza:98.45% - 99.51%Cor e Forma:SolidPeso molecular:426.94HadAB-IN-1
CAS:HadAB-IN-1: potent TB research chemical; IC50 = 0.03μM; inhibits HadAB, affecting Mtb mycolic acid synthesis.Fórmula:C19H17BrClN3O3SCor e Forma:SolidPeso molecular:482.78CDK7-IN-20
CDK7-IN-20: potent, irreversible CDK7 inhibitor, IC50 of 4nM, 206x selectivity vs. other CDKs, potential for ADPKD study.Fórmula:C30H26N6O3Cor e Forma:SolidPeso molecular:518.57SOS1-IN-15
CAS:<p>SOS1-IN-15 is an orally active and potent SOS1 inhibitor with potential antitumor activity.SOS1-IN-15 is used in the study of colon cancer.</p>Fórmula:C28H27F3N6O2Pureza:98.32%Cor e Forma:SolidPeso molecular:536.548EGFR-IN-73
CAS:EGFR-IN-73 (Compound 3f) effectively inhibits the prevalent EGFR mutation, EGFR Del19, exhibiting an IC50 value of 119 nM [1].Fórmula:C19H17ClFN3O4Pureza:98%Cor e Forma:SolidPeso molecular:405.81FUBP1-IN-2
CAS:FUBP1-IN-2 hinders FUBP1, affects c-Myc and p21 expression, and depletes polyamines.Fórmula:C26H26ClN3O4Cor e Forma:SolidPeso molecular:479.96HDAC-IN-49
<p>HDAC-IN-49: potent, broad HDAC inhibitor; IC50s: 10-1880 nM for HDAC1-6; strong anti-leukemic, low toxicity to healthy cells.</p>Fórmula:C26H27FN4O4Cor e Forma:SolidPeso molecular:478.52CU-CPT-9a
CAS:<p>CU-CPT-9a is a potent TLR8 inhibitor (IC50 : 0.5 nM), that suppresses TLR8-mediated proinflammatory signaling in various cell lines and human primary cells-</p>Fórmula:C17H15NO2Pureza:99.01%Cor e Forma:SolidPeso molecular:265.31EGFR-IN-74
EGFR-IN-74 is a potent inhibitor targeting EGFR, specifically effective against the L858R/T790M mutations, exhibiting an IC50 value of 138 nM.Fórmula:C32H28BrF3N6O4SCor e Forma:SolidPeso molecular:729.57FOXM1-IN-1
FOXM1-IN-1: Potent inhibitor of FOXM1, IC50=2.65µM, hinders cell growth & lowers FOXM1, PLK1, CDC25B levels.Fórmula:C23H30ClNO3Cor e Forma:SolidPeso molecular:403.94MMP-1-IN-1
MMP-1-IN-1 is a highly potent MMP-1 inhibitor with an IC 50 of 0.034 μM .Fórmula:C14H17ClN2O3Cor e Forma:SolidPeso molecular:296.75LRRK2-IN-7
CAS:LRRK2-IN-7: potent, selective CNS-active LRRK2 inhibitor, IC50 0.9 nM, >1000x selectivity vs kinases/channels/CYPs.Fórmula:C24H26N6OPureza:99.26%Cor e Forma:SolidPeso molecular:414.5hCAII-IN-9
CAS:<p>hCAII-IN-9 inhibits hCA II/IX/XII with IC50s of 1.18, 0.17, 2.99 μM; not BBB permeable.</p>Fórmula:C15H16ClN3O5S2Pureza:98.63%Cor e Forma:SolidPeso molecular:417.89EGFR-IN-75
EGFR-IN-75 inhibits EGFR WT/T790M; IC50s: 0.28/5.02 μM. It has anticancer and antioxidant effects.Fórmula:C10H6N6S2Cor e Forma:SolidPeso molecular:274.32HDAC-IN-50
CAS:HDAC-IN-50, a potent FGFR/HDAC inhibitor (IC50: 0.18-13 nM), induces apoptosis, cell cycle arrest, and shows anti-tumor activity.Fórmula:C31H41N7O4Cor e Forma:SolidPeso molecular:575.7Elimusertib
CAS:Elimusertib (BAY-1895344) is a potent, highly selective and orally available ATR inhibitor with an IC50 of 7 nM.Elimusertib shows potent anti-tumor efficacy inFórmula:C20H21N7OPureza:98.72% - 99.84%Cor e Forma:SolidPeso molecular:375.43NSC 295642
CAS:<p>NSC 295642: phosphatase inhibitor, boosts phospho-Erk in cells, aids cancer research.</p>Fórmula:C15H14ClCuN3S2Cor e Forma:SolidPeso molecular:399.42HDAC-IN-51
HDAC-IN-51 is an HDAC inhibitor.Fórmula:C27H24N4O2Pureza:98.85%Cor e Forma:SolidPeso molecular:436.51BSJ-04-122
CAS:BSJ-04-122: MKK4/7 inhibitor with IC50s of 4 nM & 181 nM, used in cancer research.Fórmula:C15H12ClN5OPureza:98.09%Cor e Forma:SolidPeso molecular:313.74SMYD3-IN-2
SMYD3-IN-2, a cancer research chemical, inhibits SMYD3 (IC50 0.81 μM) and BGC823 (IC50 0.75 μM), inducing fatal autophagy in gastric cancer.Fórmula:C26H21BrN2O4Cor e Forma:SolidPeso molecular:505.36BChE-IN-15
<p>BChE-IN-15 is a compound characterized as a pseudo-irreversible, covalent inhibitor of butyrylcholinesterase (BChE), demonstrating potent activity with an</p>Fórmula:C22H33N3O2Cor e Forma:SolidPeso molecular:371.52PRMT6-IN-3
CAS:PRMT6-IN-3 is a selective PRMT6 inhibitor with an IC50 value of 192 nM.PRMT6-IN-3 has anticancer activity and induces apoptosis in cancer cells.Fórmula:C19H26N4O2SPureza:98.12%Cor e Forma:SolidPeso molecular:374.5HPK1-IN-31
HPK1-IN-31 inhibitor with an IC 50 value of 0.8 nM. HPK1-IN-31 has anti-tumour activity and has great potential for immunotherapy .Fórmula:C30H33N7O3Cor e Forma:SolidPeso molecular:539.63BuChE-IN-7
<p>BuChE-IN-7: selective hBuChe & eqBuChe inhibitor, IC50s 40/80 nM, boosts cognition & memory, and penetrates blood-brain barrier.</p>Fórmula:C25H34N2O2Cor e Forma:SolidPeso molecular:394.55RK-0133114
RK-0133114, R-enantiomer of RK-701, is a G9a inhibitor (IC50 = 3.7 μM) for SCD research.Fórmula:C26H30N4O3Cor e Forma:SolidPeso molecular:446.54Ficonalkib
CAS:Ficonalkib is a potent antineoplastic agent that inhibits the Anaplastic Lymphoma Kinase (ALK) tyrosine kinase receptor.Fórmula:C29H39N7O3SCor e Forma:SolidPeso molecular:565.737-Methylguanosine
CAS:7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor (IC50 : 87.8 ± 7.5 μM).Fórmula:C11H16N5O5Pureza:98.11%Cor e Forma:SolidPeso molecular:298.28Fulzerasib
CAS:<p>Fulzerasib is an orally active KRAS G12C inhibitor that covalently binds to cysteine residue on the protein, thereby inhibiting the growth of KRAS G12C mutant</p>Fórmula:C32H30ClFN6O4Pureza:98.04%Cor e Forma:SolidPeso molecular:617.07LONP1-IN-2
CAS:LONP1-IN-2: Potent LONP1 inhibitor, IC50=0.187μM; weak on 20S proteasome (>10μM); for cancer research.Fórmula:C16H27BN4O4Cor e Forma:SolidPeso molecular:350.22DOCK2-IN-1
CAS:<p>DOCK2-IN-1, a CPYPP analogue, inhibits DOCK2 (IC50=19.1μM), reversibly binds DHR-2, and suppresses lymphocyte chemotaxis and T cell activation.</p>Fórmula:C16H11ClN2O2Cor e Forma:SolidPeso molecular:298.72EAPB 02303
CAS:<p>EAPB 02303, a microtubule inhibitor, induces mitotic arrest, spindle impairment, apoptosis, and has antitumor effects, enhancing Paclitaxel.</p>Fórmula:C17H14N4O2Cor e Forma:SolidPeso molecular:306.32RGB-286638
CAS:RGB-286638 inhibits multiple CDKs and GSK-3β, TAK1, Jak2, MEK1 with IC50s as low as 1-54 nM.Fórmula:C29H37Cl2N7O4Cor e Forma:SolidPeso molecular:618.55Piperazine
CAS:<p>Piperazine (1,4-Diazacyclohexane), a gamma-aminobutyric acid (GABA) agonist, serves as a crucial building block and core component in a wide range of marketed drugs known for their varied pharmacological activities.</p>Fórmula:C4H10N2Cor e Forma:SolidPeso molecular:86.14Nifuroxime
CAS:Nifuroxime, an anti-infective agent, is utilized in researching fungal infections.Fórmula:C5H4N2O4Cor e Forma:SolidPeso molecular:156.1Yadanzigan
CAS:<p>Yadanzigan(YDZG),a specific NLRP3 inhibitor, attenuates the NF-κB pathway and reactive oxygen species generation, while enhancing TRIM31, anti-inflammatory.</p>Fórmula:C26H38O14Pureza:99.98%Cor e Forma:SolidPeso molecular:574.57Tozadenant
CAS:Tozadenant (SYN115) is an adenosine A2A receptor antagonist(Ki of 11.5 nM and 6 nM on human and rhesus,respectively)Fórmula:C19H26N4O4SPureza:98%Cor e Forma:SolidPeso molecular:406.5Stigmane B
<p>Stigmane B activates Nrf2, decreases apoptosis and ROS, boosts antioxidants, and is neuroprotective.</p>Fórmula:C21H30O4Cor e Forma:SolidPeso molecular:346.46BChE-IN-11
CAS:BChE-IN-11: potent, selective, non-competitive BChE inhibitor; IC50=2.1μM; used in AD research.Fórmula:C22H18O4Cor e Forma:SolidPeso molecular:346.38Praelolide
Praelolide activates Nrf2, hinders osteoclastogenesis/ROS, binds Keap1 noncovalently, may aid bone disease research.Fórmula:C28H35ClO12Cor e Forma:SolidPeso molecular:599.02Wikstrol A
CAS:Wikstrol A: antifungal, anti-mitotic, anti-HIV agent with various IC50/MDC values (67.8-131 µM) and deforms P. oryzae mycelia.Fórmula:C30H22O10Cor e Forma:SolidPeso molecular:542.49Laburnetin
CAS:Laburnetin: an isoflavone antibacterial, combats fungi/S. vesicarium, boosts MRSA methicillin susceptibility, used in pest control.Fórmula:C20H18O6Cor e Forma:SolidPeso molecular:354.35Olamkicept
CAS:Olamkicept (FE-301) is a soluble gp130-Fc-fusion protein that inhibits interleukin 6 (IL-6) trans signaling.Pureza:98.2% (SDS-PAGE); 98.8% (SEC-HPLC) - 99.3% (SDS-PAGE); 97.6% (SEC-HPLC)Cor e Forma:LiquidMBP146-78
CAS:<p>MBP146-78 is a potent and selective cGMP inhibitor dependent protein kinases.</p>Fórmula:C21H22FN3Pureza:99.33%Cor e Forma:SolidPeso molecular:335.42Notum-IN-1
CAS:Notum-IN-1 is an orally administered, selective, and brain-penetrating compound that acts as an inhibitor of Notum.Fórmula:C9H7Cl2N3OCor e Forma:SolidPeso molecular:244.08RX 801077
CAS:RX 801077 is a selective I2R agonist, Ki of 70.1 nM, with anti-inflammatory and neuroprotective properties for TBI research.Fórmula:C11H10N2OCor e Forma:SolidPeso molecular:186.21PD 168568
CAS:PD 168568: Oral DRD4 antagonist, selective over D2/D3, K_i - 8.8 nM. Used in GBM research.Fórmula:C22H27N3OCor e Forma:SolidPeso molecular:349.47Gepefrine
CAS:Gepefrine为具口服活性的升压剂及拟交感神经作用剂，能有效改善动脉压早期直立性失调。Fórmula:C9H13NOCor e Forma:SolidPeso molecular:151.21Crisnatol
CAS:<p>Crisnatol (BWA770U) is an oral anticancer DNA intercalator, toxic to breast cancer cells, not skin fibroblasts.</p>Fórmula:C23H23NO2Cor e Forma:SolidPeso molecular:345.43Epitizide
CAS:Epitizide, a benzothiadiazine, commonly found in combination Triamterene , is used to produce diuresis [1] .Fórmula:C10H11ClF3N3O4S3Cor e Forma:SolidPeso molecular:425.86Theliatinib
CAS:<p>Theliatinib: potent, selective EGFR inhibitor, anti-tumor; Ki=0.05 nM (EGFR), IC50=3 nM (EGFR), 22 nM (T790M/L858R).</p>Fórmula:C25H26N6O2Pureza:99.67%Cor e Forma:SolidPeso molecular:442.51RO5461111
CAS:RO5461111: Oral Cathepsin S inhibitor, IC50 of 0.4 nM (human) & 0.5 nM (mouse), reduces T/B cell activation, treats lung inflammation & lupus nephritis.Fórmula:C27H24F6N4O4SCor e Forma:SolidPeso molecular:614.56CASK-IN-1
CAS:CASK-IN-1 is a highly potent and selective CASK inhibitor with a K d value of 0.022 μM.Fórmula:C24H30Br2N6O3Cor e Forma:SolidPeso molecular:610.34LDHA-IN-5
CAS:LDHA-IN-5 is a novel and potent inhibitor targeting both glycolate oxidase (GO) and lactate dehydrogenase A (LDHA), designed for the treatment of primaryFórmula:C27H22FN7O6S3Cor e Forma:SolidPeso molecular:655.7NS5A-IN-3
CAS:<p>NS5A-IN-3 is a potent NS5A inhibitor with high efficacy against HCV 1b, good activity on 3a, and strong metabolic stability; superior to daclatasvir.</p>Fórmula:C44H44N6O8Pureza:98%Cor e Forma:SolidPeso molecular:784.86AMPK-IN-1
CAS:AMPK-IN-1 is an activator of the AMP-activated protein kinase (AMPK) enzyme, specifically targeting the α2β2γ1 isoform with an EC50 of 551 nM.Fórmula:C24H18ClN3O3Cor e Forma:SolidPeso molecular:431.87OTS193320
CAS:OTS193320, an imidazo[1,2-a]pyridine, inhibits SUV39H2, reduces H3K9me3, and induces apoptosis in breast cancer; enhances DOX effects.Fórmula:C28H30ClN5O4Cor e Forma:SolidPeso molecular:536.02SH-BC-893
CAS:SH-BC-893: Oral anti-cancer sphingolipid analog, prevents ceramide-related mitochondrial issues, and tackles diet-related obesity.Fórmula:C19H32ClNOCor e Forma:SolidPeso molecular:325.92Artonin E
CAS:Artonin E, a prenylated flavonoid, induces apoptosis and S-phase arrest, disrupting the mitochondrial pathway for cancer research.Fórmula:C25H24O7Cor e Forma:SolidPeso molecular:436.45Mps1-IN-4
CAS:Mps1-IN-4 is a compound that selectively inhibits Monopolar spindle 1 (Mps1), exhibiting antiproliferative properties useful in cancer research.Fórmula:C26H31F3N6O2Cor e Forma:SolidPeso molecular:516.56BCI-215
CAS:<p>BCI-215 causes selective cancer cell cytotoxicity in part through non-redox-mediated activation of MAPK signaling</p>Fórmula:C22H22BrNOPureza:99.812%Cor e Forma:SolidPeso molecular:396.32UT-B-IN-1
CAS:<p>UT-B-IN-1: reversible UT-B inhibitor, IC50: 10 nM (human), 25 nM (mouse), low toxicity, diuretic research tool.</p>Fórmula:C20H17N5O2S3Cor e Forma:SolidPeso molecular:455.58RR-RJW100
RR-RJW100: potent LRH-1 & SF-1 agonist; studies metabolic disorders, diabetes, liver disease, IBD.Fórmula:C28H34OCor e Forma:SolidPeso molecular:386.57Ciramadol
CAS:Ciramadol (WY 15705) is a potent analgesic with dual narcotic effects, used in postoperative pain research.Fórmula:C15H23NO2Cor e Forma:SolidPeso molecular:249.35USP7-797
CAS:USP7-797 is a selective non-covalent active site USP7 inhibitor, inhibiting USP7 and ubiquitin binding, with anti-tumor, oral and high efficiency properties.Fórmula:C27H28ClN3O3SPureza:95.90%Cor e Forma:SolidPeso molecular:510.05GPX4-IN-2
CAS:GPX4-IN-2 is a potent inhibitor of GPX4, exhibiting antiproliferative activity. It holds potential for cancer research applications.Fórmula:C30H40N2OCor e Forma:SolidPeso molecular:444.65gTPA2-OMe
gTPA2-OMe is a potential hole transport layer candidate for perovskite solar cells (PSCs).Fórmula:C32H33N7O2Cor e Forma:SolidPeso molecular:547.65DC-BPi-11
CAS:DC-BPi-11 inhibits BPTF at IC50 698 nM and significantly reduces leukemia cell growth.Fórmula:C20H23N5O2SCor e Forma:SolidPeso molecular:397.49Chelidonine hydrochloride
CAS:Chelidonine hydrochloride is one of the alkaloids of Chelidonium majus, which has broad pharmacological activitiesFórmula:C20H20ClNO5Pureza:>99.99%Cor e Forma:SolidPeso molecular:389.83PDE5-IN-4
CAS:PDE5-IN-4, a phosphodiesterase 5 (PDE5) inhibitor, is utilized in research concerning acute myocardial infarction and reperfusion-related damage,Fórmula:C21H27N5O5SCor e Forma:SolidPeso molecular:461.53NSD3-IN-1
CAS:NSD3-IN-1, a histone methyltransferase NSD3 inhibitor, demonstrates an IC50 of 28.58 μM.Fórmula:C13H13N5OSCor e Forma:SolidPeso molecular:287.34NSD3-IN-2
CAS:NSD3-IN-2: Potent NSD3 inhibitor, IC50 17.97μM, halts NSCLC growth (H460, H1299, H1650) with anticancer effects.Fórmula:C17H15N5OSCor e Forma:SolidPeso molecular:337.4NSD3-IN-3
CAS:"NSD3-IN-3, a potent anticancer agent, inhibits NSD3 (IC50: 1.86 μM) and hampers H460 lung cancer cell growth."Fórmula:C15H17N5O2SCor e Forma:SolidPeso molecular:331.39AChE-IN-9
AChE-IN-9: Tacrine-β-glucose glycoconjugate; IC50 0.4μM; reduced hepatotoxicity; Alzheimer's research.Fórmula:C30H35N5O9Cor e Forma:SolidPeso molecular:609.63EZH2-IN-7
CAS:<p>EZH2-IN-7 inhibits EZH2, reducing H3K27me3 and tumor growth (e.g., breast, prostate cancer, leukemia). Potential in cancer research.</p>Fórmula:C31H37D2N5O3SCor e Forma:SolidPeso molecular:563.75PIM1-IN-4
CAS:<p>PIM1-IN-4: strong PIM1 inhibitor, also blocks SGK-1, PKA, CaMK-1, GSK3β, MSK1; promising for cancer studies.</p>Fórmula:C27H25BrCl2CuN6OPureza:98%Cor e Forma:SolidPeso molecular:663.88RET-IN-13
CAS:RET-IN-13: potent quinoline RET inhibitor; IC50 = 0.5 nM (WT), 0.9 nM (V804M); potential for RET-related tumor/intestinal disease research.Fórmula:C32H33F4N5O3Cor e Forma:SolidPeso molecular:611.63HBV-IN-15
CAS:HBV-IN-15, a flavone derivative, is a potent cccDNA inhibitor, potentially aiding HBV research.Fórmula:C24H23ClO6Cor e Forma:SolidPeso molecular:442.89JAK-IN-17
"JAK-IN-17: Potent JAK inhibitor for studying ocular, skin, and respiratory diseases."Fórmula:C33H38F2N6O8Cor e Forma:SolidPeso molecular:684.69EIDD-2749
CAS:<p>EIDD-2749 (4'-Fluorouridine), an oral drug, inhibits RdRp, halts RSV/SARS-CoV-2 replication, and fights HCV/LCMV.</p>Fórmula:C9H11FN2O6Pureza:97.39%Cor e Forma:SolidPeso molecular:262.19TrxR-IN-4
CAS:TrxR-IN-4, a strong TrxR inhibitor, induces ERS, apoptosis in HepG2 cells, reduces liver damage by lowering TrxR and inflammation.Fórmula:C28H20AuF8N2O2PCor e Forma:SolidPeso molecular:796.4Akt1-IN-1
Akt1-IN-1: Potent, selective Akt1 inhibitor, IC50 18.79 nM, non-teratogenic/hepatotoxic/cardiotoxic, useful in cancer research.Fórmula:C31H34FN5O5S2Cor e Forma:SolidPeso molecular:639.76RET-IN-16
CAS:RET-IN-16: Selective RET inhibitor, IC50s 3.98-15.05 nM for various RET mutations; anticancer properties.Fórmula:C31H29F3N8O2Cor e Forma:SolidPeso molecular:602.61USP7-IN-9
USP7-IN-9 is a potent USP7 inhibitor (IC50 = 40.8 nM), induces apoptosis, arrests RS4;11 cells, and modulates key oncoproteins.Fórmula:C32H33ClF6N6O8Cor e Forma:SolidPeso molecular:779.086H05 (TFA)
CAS:6H05 TFA (6H05 trifluoroacetate) is a selective, and allosteric oncogenic mutant K-Ras(G12C) inhibitor.Fórmula:C22H31ClF3N3O4S3Pureza:98.83%Cor e Forma:SolidPeso molecular:590.14C5aR-IN-1
CAS:C5aR-IN-1, a potent C5aR inhibitor, may aid in researching autoimmune and inflammatory diseases.Fórmula:C36H39F4N3O2Cor e Forma:SolidPeso molecular:621.71C5aR-IN-3
CAS:C5aR-IN-3, a potent C5aR inhibitor, may treat autoimmune and inflammatory diseases.Fórmula:C36H40FN5O3Cor e Forma:SolidPeso molecular:609.73L2H2-6OTD
CAS:L2H2-6OTD is a telomerase inhibitor with G-quadruplex loops; IC50: 15 nM.Fórmula:C30H30N10O8Cor e Forma:SolidPeso molecular:658.62Tolindate
CAS:Tolindate, a potent PXR agonist, demonstrates antifungal activity and possesses an EC50 value of 8.3 µM.Fórmula:C18H19NOSCor e Forma:SolidPeso molecular:297.41NVS-MALT1
CAS:<p>NVS-MALT1 is an allosteric inhibitor of MALT1 [1].</p>Fórmula:C24H27ClF3N5O4SCor e Forma:SolidPeso molecular:574.02VU6036720
<p>VU6036720 is a potent and selective inhibitor of the isomeric Kir4.1/5.1.VU6036720 inhibits Kir4.1/5.1 activity by decreasing the channel open-circuit</p>Fórmula:C20H22ClFN4O2SPureza:98.1%Cor e Forma:SoildPeso molecular:436.93hRSV-IN-1
CAS:<p>hRSV-IN-1 is an inhibitor of respiratory syncytial virus (hRSV) .</p>Fórmula:C24H25N5O3SCor e Forma:SolidPeso molecular:463.55
